Form4insider filings, from the source

SEC Form 4 · accession 0001437749-18-001302

ZEVRA THERAPEUTICS, INC. · ZVRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Travis C Mickle
Officer — President & CEO · Director · 10% Owner
Period of report
Jan 25, 2018
Accepted (ET)
Jan 29, 2018 · 6:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434647

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F1$5.50Jan 25, 2018A225,000A—Jan 24, 2028Common Stock225,000225,000D
Stock Option (right to buy)F2$5.50Jan 25, 2018A30,000A—Jan 24, 2028Common Stock30,00030,000I

Explanation of responses

Remarks

Exhibit List: Exhibit 24 - Power of Attorney.